Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prowess is a private medical technology company focused on radiation oncology software for cancer treatment planning and workflow management. The company develops vendor-neutral, FDA 510(k)-cleared and ISO 13485-compliant software products, centered on its Panther platform, including Panther TPS for treatment planning and Panther OIS for oncology information management. Its treatment planning capabilities span VMAT, IMRT, 3D conformal radiotherapy, brachytherapy, stereotactic radiotherapy, and simulation tools. Prowess markets its software globally through distributors and regional partners and reports use in more than 65 countries. The business is best characterized as a commercial-stage oncology software and medical device company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prowess.